Thalidomide therapy for gastrointestinal angiodysplasia;Thalidomidbehandling af gastrointestinal angiodysplasi

Ugeskrift for Laeger

Volumn 171, Issue 47, 2009, Pages

  Bélard, Erika ^a   Foss, Catherine H ^a   Christensen, Lisbeth Ambrosius ^a   Schmidt, Palle ^a   Nøjgaard, Camilla ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; THALIDOMIDE;

ANGIODYSPLASIA; ARTICLE; CASE REPORT; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MIDDLE AGED; RECURRENT DISEASE; TREATMENT OUTCOME;

ANGIODYSPLASIA; ANGIOGENESIS INHIBITORS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MIDDLE AGED; RECURRENCE; THALIDOMIDE; TREATMENT OUTCOME;

EID: 77954844692     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Canada: Saunders Elsevier, 2006.
2. American Gastroenterological Association, American Gastroenterological Association Medical Position Statement: Evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology 2000;118:197-200.
3. Powell RJ. Thalidomide, treat with caution. Neth J Med 2006;64:422-4.
4. Bauditz J, Lochs H, Voderholzer W. Thalidomide for treatment of severe intestinal bleeding. Gut. 2004;53:609-12.
5. Heidt J, Langers AMJ, van der Meer FJM et al. Thalidomide as treatment for di-gestive tract angiodysplasias. Neth J Med 2006;64:391-2.